It is well known that the renin-angiotensin system (RAS), including angiotensinogen, renin, angiotensin-converting enzyme, angiotensin II type 1 receptor (AT1R) and angiotensin II type 2 receptor (AT2R), is activated inappropriately in the diseased kidney during CKD progression. This evidence concerns the gene REN and chronic kidney disease.